{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T14:51:14Z","timestamp":1726411874537},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1984,2,1]],"date-time":"1984-02-01T00:00:00Z","timestamp":444441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[1984,2]]},"DOI":"10.1007\/bf00395488","type":"journal-article","created":{"date-parts":[[2004,11,8]],"date-time":"2004-11-08T10:46:01Z","timestamp":1099910761000},"page":"38-41","source":"Crossref","is-referenced-by-count":5,"title":["4?-Epi-doxorubicin ? A clinical phase-II trial in solid tumors"],"prefix":"10.1007","volume":"107","author":[{"given":"J.","family":"Sch\ufffdtte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Niederle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Grunenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Krischke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"123","volume":"6","author":"F Arcamone","year":"1975","unstructured":"Arcamone F, Penco S, Vigevani A (1975) Adriamycin: new chemical development and analogs. Cancer Chem Rep 6:123?129","journal-title":"Cancer Chem Rep"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/jm00241a013","volume":"18","author":"F Arcamone","year":"1975","unstructured":"Arcamone F, Penco S, Vigevani A, Redaelli S, Franchi G, Di Marco A, Casazza AM, Dasdia T, Formelli F, Necco A, Soranzo C (1975) Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. J Med Chem 18:703?707","journal-title":"J Med Chem"},{"key":"CR3","first-page":"915","volume":"63","author":"V Bonfante","year":"1979","unstructured":"Bonfante V, Bonadonna G, Villani F, Di Fronzo G, Martini A, Casazza AM (1979) Preliminary phase-I study of 4?-epi-adriamycin. Cancer Treat Rep 63:915?918","journal-title":"Cancer Treat Rep"},{"key":"CR4","unstructured":"Casazza AM, Di Marco A, Bertazzoli C, Formelli F (1978) Antitumor activity, toxicity and pharmacological properties of 4?-epi-adriamycin. In: Current chemotherapy. American Society for Microbiology; International Society of Chemotherapy (pp 1257?1260)"},{"key":"CR5","first-page":"835","volume":"63","author":"AM Casazza","year":"1979","unstructured":"Casazza AM (1979) Experimental evaluation of anthracycline analogs. Cancer Treat Rep 63:835?844","journal-title":"Cancer Treat Rep"},{"key":"CR6","first-page":"1219","volume":"66","author":"SD Foss\u00e4","year":"1982","unstructured":"Foss\u00e4 SD, Wik B, Bae F, Lien HH (1982) Phase-II study of 4?-epi-doxorubicin in metastatic renal cancer. Cancer Treat Rep 66:1219?1221","journal-title":"Cancer Treat Rep"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0305-7372(83)80029-2","volume":"10","author":"F Ganzina","year":"1983","unstructured":"Ganzina F (1983) 4?-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. Cancer Treat Rev 10:1?22","journal-title":"Cancer Treat Rev"},{"key":"CR8","unstructured":"Giulani FC, Kaplan NO, Coirin AK, Howell SB (1980) Screening of new doxorubicin analogs with activity against human colon carcinoma xenografts. AACR & ASCO Proceedings (abstract 1090, vol. 21, March)"},{"key":"CR9","first-page":"1063","volume":"65","author":"FC Giulani","year":"1981","unstructured":"Giulani FC, Coirin AK, Rene Rice M, Kaplan NO (1981) The effect of 4?-epi-doxorubicin analogs on heterotransplantation of human tumors in congenitally athymic mice. Cancer Treat Rep 65:1063?1075","journal-title":"Cancer Treat Rep"},{"key":"CR10","unstructured":"Pannuti F, Martoni A, Giovannini M, Iafelice G, Burroni P, Strocchi E, Bellanova B, Monetti M, Rossini G, Tarquini M, Toschi GP (1981) 4?-epi-adriamycin: a phase-II clinical study. 12th International Congress of Chemotherapy, Florence (abstract 350, p 115)"},{"key":"CR11","first-page":"433","volume":"4","author":"PK Schauer","year":"1981","unstructured":"Schauer PK, Wittes RE, Gralla RJ, Casper ES, Young CW (1981) A phase-I trial of 4?-epi-doxorubicin. Cancer Clinical Trials 4:433?437","journal-title":"Cancer Clinical Trials"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00406927","volume":"105","author":"J Schuette","year":"1983","unstructured":"Schuette J, Niederle N, Seeber S (1983) Phase-II trial of aclacinomycin A in acute leukemia and various solid tumors. J Cancer Res Clin Oncol 105:162?165","journal-title":"J Cancer Res Clin Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/030089168006600603","volume":"66","author":"FP Villani","year":"1980","unstructured":"Villani FP, Favalli L, Piccinini F (1980) Relationship between the effect on calcium turnover and early cardiotoxicity of doxorubicin and 4?-epi-doxorubicin in guinea pig heart muscle. Tumori 66:689?697","journal-title":"Tumori"},{"key":"CR14","unstructured":"Young CW, Wittes RE, Jain K, Casper ES (1983) Clinical evaluation of 4?-epi-doxorubicin. 13th International Congress of Chemotherapy, Vienna (Proceedings, Part 215, pp 13?16)"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00395488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00395488\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00395488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T18:28:57Z","timestamp":1554316137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00395488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984,2]]}},"alternative-id":["BF00395488"],"URL":"https:\/\/doi.org\/10.1007\/bf00395488","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[1984,2]]}}}